UBS Group AG - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 42 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$186,8001,0000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 55,277,000$84,644,0004.13%
STEELHEAD PARTNERS LLC 19,300,000$29,580,0002.91%
LINDEN ADVISORS LP 95,377,000$145,892,0002.59%
WOLVERINE ASSET MANAGEMENT LLC 89,141,000$136,310,0001.98%
Verition Fund Management LLC 14,735,000$22,403,0000.88%
ADVENT CAPITAL MANAGEMENT /DE/ 20,376,000$31,177,0000.68%
Nicholas Investment Partners, LP 1,950,000$2,960,0000.58%
TENOR CAPITAL MANAGEMENT Co., L.P. 7,500,000$11,527,0000.56%
SSI INVESTMENT MANAGEMENT LLC 3,009,000$4,572,0000.40%
Calamos Advisors LLC 26,471,000$40,570,0000.32%
View complete list of SAREPTA THERAPEUTICS INC shareholders